Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington’s disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol

Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington’s disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol

Introduction Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder that presents with a progressive movement disorder along with cognitive and psychiatric problems. It is caused by a Cytosine-adenin-guanine (CAG) expansion in exon 1 of the huntingtin gene which codes for muta...

Full description

Saved in:
Bibliographic Details
Main Authors: Roger A Barker, Laura Oakley, Emma Cutting, David C Rubinsztein, Dimitrios Apostolopoulos, Nikolaos Demiris, Katie Andresen, Amy H Evans, Alimu Dayimu, Katherine Bongaerts, Robyn Staples, Wendy Gooding
Format: Article
Language:English
Published: BMJ Publishing Group 2024-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/8/e087983.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items